Tellgen Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002P42
  • SHE: 300642
CNY
21.02
0.67 (3.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
104.73
82.61
106.22
98.55
84.17
74.89
115.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
104.73
82.61
106.22
98.55
84.17
74.89
115.86
Raw Material Cost
44.08
40.36
37.30
44.02
39.09
38.90
48.74
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
2.14
0.28
0.00
0.15
0.13
Selling and Distribution Expenses
19.76
33.22
44.54
33.14
29.44
32.14
32.72
Other Expenses
1.48
1.01
1.42
1.45
0.96
0.85
1.41
Total Expenditure (Excl Depreciation)
78.66
83.68
98.18
91.95
78.14
79.67
95.70
Operating Profit (PBDIT) excl Other Income
26.099999999999998
-1.1
8
6.6000000000000005
6
-4.8
20.2
Other Income
-1.79
-0.51
4.72
1.51
2.52
4.18
4.65
Operating Profit (PBDIT)
33.77
12.21
18.56
21.12
21.71
16.17
34.11
Interest
0.00
0.00
2.14
0.28
0.00
0.15
0.13
Exceptional Items
4.26
0.71
-2.49
-0.65
0.91
0.46
-1.08
Gross Profit (PBDT)
60.66
42.25
68.92
54.53
45.07
36.00
67.12
Depreciation
14.76
14.76
14.51
14.51
17.56
17.56
14.98
Profit Before Tax
23.28
-1.84
-0.57
5.69
5.06
-1.08
17.93
Tax
3.55
0.40
-2.34
-0.10
0.54
-0.15
4.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.04
-5.56
-2.19
3.02
2.29
0.47
10.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.04
-5.56
-2.19
3.02
2.29
0.47
10.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.01
-0.69
-1.48
-0.51
-1.03
-1.40
-1.53
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.03
-6.25
-3.66
2.51
1.26
-0.92
8.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,437.29
1,420.74
1,426.41
1,471.07
1,487.79
1,506.26
1,507.49
Earnings per share (EPS)
0.11
-0.03
-0.01
0.02
0.01
0.0
0.06
Diluted Earnings per share
0.11
-0.03
-0.01
0.02
0.01
0.0
0.06
Operating Profit Margin (Excl OI)
19.86%
-2.47%
-0.63%
5.18%
1.93%
-7.45%
12.5%
Gross Profit Margin
36.32%
15.64%
13.12%
20.49%
26.88%
22.01%
28.41%
PAT Margin
16.27%
-6.73%
-2.06%
3.06%
2.72%
0.63%
8.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 26.76% vs -22.22% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 369.84% vs -70.27% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 180.31% vs -7.97% in Mar 2026

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Tellgen Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
104.73
0
104.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
104.73
0
104.73
Raw Material Cost
44.08
0
44.08
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
19.76
0
19.76
Other Expenses
1.48
0.00
1.48
Total Expenditure (Excl Depreciation)
78.66
0
78.66
Operating Profit (PBDIT) excl Other Income
26.07
0.00
26.07
Other Income
-1.79
0
-1.79
Operating Profit (PBDIT)
33.77
0
33.77
Interest
0.00
0
0.00
Exceptional Items
4.26
0
4.26
Gross Profit (PBDT)
60.66
0
60.66
Depreciation
14.76
0
14.76
Profit Before Tax
23.28
0
23.28
Tax
3.55
0
3.55
Provisions and contingencies
0
0
0.00
Profit After Tax
17.04
0
17.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.04
0
17.04
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.01
0
-0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.03
0
17.03
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,437.29
0
1,437.29
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
19.86%
0%
0.00
19.86%
Gross Profit Margin
36.32%
0%
0.00
36.32%
PAT Margin
16.27%
0%
0.00
16.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 10.47 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 26.76% vs -22.22% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 24.35% vs -31.32% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.70 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 369.84% vs -70.27% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1,207.69% vs -86.46% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.56 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 180.31% vs -7.97% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 85.42% vs -38.26% in Jun 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.86%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025